Clinical Trial

Non Invasive Measurement With Trans Cranial Doppler Versus Invasive Measurement in Pediatric Age

Study acronym: nICPped
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 28, 2025 (before its estimated June 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
An increase of intracranial pressure (ICP) is an important cause of secondary brain damage. The gold standard for measuring ICP is represented by invasive positioning of intracranial ICP devices. The most used non-invasive methods (nICP) are obtained through bed-side ultrasound, routinely used in the management of children in Pediatric Intensive Care: arterial Trancranial Doppler (TCD) and ultrasound measurement of the diameter of the optic nerve sheath (ONSD ). In this study it is proposed to compare the measurement of nICP obtained by TCD and ONSD versus the measurement obtained by the invasive monitoring (iICP) already present.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-04-20; most recent amendment 2025-01-27.
Status change: Not Yet Recruiting → Recruiting 2022-07-18
Trial Details
NCT Number NCT05340062
Lead Sponsor Azienda Ospedaliera di Padova
Conditions Intracranial Hypertension
Enrollment 46 participants
Start Date 2022-07-01
Primary Completion 2025-06-30 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-01-28